SCHEMBL31000906

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	4/20	0.59

▸	CALCRL	Q16602	5/20	0.58

▸	EP300	Q09472	1/20	0.56

▸	HIF1A	Q16665	1/20	0.56

▸	CRHR1	P34998	1/20	0.53

▸	CRHR2	Q13324	1/20	0.53

▸	MAPK8	P45983	1/20	0.53

▸	MAPK9	P45984	1/20	0.53

▸	MAPK10	P53779	1/20	0.53

▸	KEAP1	Q14145	1/20	0.53

▸	F2	P00734	1/20	0.53

▸	OPRD1	P41143	1/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30277935	0.98	CALCR (0.61)	CALCRCALCRLEP300HIF1ACRHR1
SCHEMBL31000879	0.96	CALCRL (0.60)	CALCRCALCRLEP300HIF1ACRHR1
SCHEMBL30277946	0.93	CALCR (0.60)	CALCRCALCRLEP300HIF1AKEAP1
SCHEMBL31000872	0.90	CALCR (0.60)	CALCREP300HIF1AKEAP1F2
SCHEMBL30648485	0.89	CALCR (0.66)	CALCREP300HIF1ACRHR1CRHR2
SCHEMBL31000946	0.88	CALCR (0.64)	CALCREP300HIF1ACRHR1CRHR2
SCHEMBL30712880	0.88	CALCR (0.61)	CALCREP300HIF1ACRHR1CRHR2
SCHEMBL30495733	0.88	EP300 (0.66)	CALCREP300HIF1ACRHR1CRHR2
SCHEMBL30429242	0.88	CALCR (0.63)	CALCREP300HIF1ACRHR1CRHR2
SCHEMBL31182731	0.87	CALCR (0.65)	CALCREP300HIF1ACRHR1CRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4630447-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	Abwiz Bio, Inc. (US)	2025-10-15	—	—	EP	disclosed
WO-2024124241-A2	ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF	ABWIZ BIO, INC. (US)	2024-06-13	—	—	WO	disclosed